{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:54:44Z","timestamp":1790456084165,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.amjcard.2020.01.037","type":"journal-article","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T11:06:59Z","timestamp":1581160019000},"page":"1582-1593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension"],"prefix":"10.1016","volume":"125","author":[{"given":"Brian","family":"Olshansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Muldowney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.01.037_bib0001","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMcp074189","article-title":"Clinical practice. Neurogenic orthostatic hypotension","volume":"358","author":"Freeman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0002","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0003","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12883-018-1129-x","article-title":"Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers","volume":"18","author":"Claassen","year":"2018","journal-title":"BMC Neurol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/mds.27268","article-title":"Autonomic dysfunction in Parkinson's disease: a prospective cohort study","volume":"33","author":"Merola","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0005","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","article-title":"Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets","volume":"15","author":"Espay","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0006","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0007","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/eurheartj\/ehy037","article-title":"2018 ESC guidelines for the diagnosis and management of syncope","volume":"39","author":"Brignole","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0008","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/eurheartj\/ehv093","article-title":"Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies","volume":"36","author":"Ricci","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0009","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/heartjnl-2013-304121","article-title":"Orthostatic hypotension and mortality risk: a meta-analysis of cohort studies","volume":"100","author":"Xin","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0010","first-page":"101","article-title":"Mortality and prognosis in patients with neurogenic orthostatic hypotension","volume":"27","author":"Maule","year":"2012","journal-title":"Funct Neurol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0011","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1212\/WNL.0000000000002086","article-title":"Survival in synucleinopathies: a prospective cohort study","volume":"85","author":"Goldstein","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0012","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2017.11.344","article-title":"Orthostatic hypotension in Parkinson disease: impact on health care utilization","volume":"47","author":"Merola","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0013","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/13696998.2017.1284668","article-title":"Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson's disease","volume":"20","author":"Francois","year":"2017","journal-title":"J Med Econ"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10286-009-0043-0","article-title":"Cardiac ectopy in chronic autonomic failure","volume":"20","author":"Goldstein","year":"2010","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ehf2.12223","article-title":"Autonomic dysfunction is associated with cardiac remodelling in heart failure patients","volume":"5","author":"Ali","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0016","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ajh\/hpv187","article-title":"Orthostatic hypotension and cardiac changes after long-term follow-up","volume":"29","author":"Magnusson","year":"2016","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0017","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.amjcard.2017.11.036","article-title":"Relation of orthostatic hypotension with new-onset atrial fibrillation (from the Framingham Heart Study)","volume":"121","author":"Ko","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0018","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2796.2010.02261.x","article-title":"Orthostatic hypotension and long-term incidence of atrial fibrillation: the Malmo Preventive Project","volume":"268","author":"Fedorowski","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0019","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/HYPERTENSIONAHA.115.05913","article-title":"Cardiac organ damage and arterial stiffness in autonomic failure: comparison with essential hypertension","volume":"66","author":"Milazzo","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0020","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/jnnp-2014-309999","article-title":"New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study","volume":"87","author":"Pavy-Le Traon","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0021","first-page":"473","article-title":"The impact of supine hypertension on target organ damage and mortality in patients with neurogenic orthostatic hypotension [Abstract]","volume":"28","author":"Palma","year":"2018","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0022","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10286-015-0336-4","article-title":"Supine hypertension in Parkinson's disease and multiple system atrophy","volume":"26","author":"Fanciulli","year":"2016","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0023","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/jnnp.2007.120980","article-title":"Why old people fall (and how to stop them)","volume":"7","author":"Voermans","year":"2007","journal-title":"Pract Neurol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0024","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.HYP.30.5.1062","article-title":"The hypertension of autonomic failure and its treatment","volume":"30","author":"Shannon","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mds.26079","article-title":"Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?","volume":"30","author":"Palma","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"Fanciulli","year":"2018","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0027","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.111.00377","article-title":"Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure","volume":"61","author":"Arnold","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0028","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","article-title":"Clinical characteristics of supine hypertension in de novo Parkinson disease","volume":"26","author":"Umehara","year":"2016","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0029","doi-asserted-by":"crossref","first-page":"e652","DOI":"10.1212\/WNL.0000000000005994","article-title":"The efficacy of nonpharmacologic intervention for orthostatic hypotension associated with aging","volume":"91","author":"Newton","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","article-title":"Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial","volume":"83","author":"Kaufmann","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0031","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","article-title":"Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa","volume":"65","author":"Biaggioni","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JPD-130259","article-title":"Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (NOH306A)","volume":"4","author":"Hauser","year":"2014","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0033","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mds.26086","article-title":"Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson's disease (nOH306B)","volume":"30","author":"Hauser","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0034","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JPD-160860","article-title":"Safety and durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH303)","volume":"6","author":"Isaacson","year":"2016","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jash.2016.07.010","article-title":"Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension","volume":"10","author":"Isaacson","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0036","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1212\/WNL.53.9.2151","article-title":"The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial","volume":"53","author":"Freeman","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0037","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","article-title":"Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine","volume":"95","author":"Jankovic","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0038","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","article-title":"Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study","volume":"277","author":"Low","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0039","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"Wright","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10286-016-0363-9","article-title":"Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study","volume":"26","author":"Smith","year":"2016","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0041","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/diab.24.4.381","article-title":"9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy","volume":"24","author":"Campbell","year":"1975","journal-title":"Diabetes"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0042","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/bmj.1.6014.872","article-title":"Therapeutic experience with fludrocortisone in diabetic postural hypotension","volume":"1","author":"Campbell","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0043","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archneur.1975.00490430072013","article-title":"Levodopa-induced postural hypotension. Treatment with fludrocortisone","volume":"32","author":"Hoehn","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0044","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/hrt.76.6.507","article-title":"Fludrocortisone in the treatment of hypotensive disorders in the elderly","volume":"76","author":"Hussain","year":"1996","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006848","article-title":"Fludrocortisone is associated with a higher risk of all-cause hospitalizations compared with midodrine in patients with orthostatic hypotension","volume":"6","author":"Grijalva","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0046","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0140-6736(86)92428-1","article-title":"Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995","volume":"2","author":"Hoeldtke","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0047","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0002-9343(89)90442-7","article-title":"Effect of the somatostatin analogue SMS-201-995 on the adrenergic response to glucose ingestion in patients with postprandial hypotension","volume":"86","author":"Hoeldtke","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0048","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1210\/jcem-68-6-1051","article-title":"Treatment of orthostatic hypotension with octreotide","volume":"68","author":"Hoeldtke","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0049","first-page":"1664","article-title":"Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure","volume":"13","author":"Alam","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00002826-199502000-00012","article-title":"Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration","volume":"18","author":"Bordet","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0051","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.111.184812","article-title":"Synergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure","volume":"59","author":"Okamoto","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0052","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0002-9343(98)00193-4","article-title":"Contrasting actions of pressor agents in severe autonomic failure","volume":"105","author":"Jordan","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0053","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.37.2.215","article-title":"Oral yohimbine in human autonomic failure","volume":"37","author":"Onrot","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0054","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/HYPERTENSIONAHA.110.154898","article-title":"Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure","volume":"56","author":"Shibao","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0055","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-121-3-199408010-00004","article-title":"The anemia of primary autonomic failure and its reversal with recombinant erythropoietin","volume":"121","author":"Biaggioni","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0056","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJM199308263290904","article-title":"Treatment of orthostatic hypotension with erythropoietin","volume":"329","author":"Hoeldtke","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0057","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","article-title":"Pyridostigmine treatment trial in neurogenic orthostatic hypotension","volume":"63","author":"Singer","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0058","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.107.089961","article-title":"Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function","volume":"50","author":"Shibao","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0059","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.04225","article-title":"Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure","volume":"64","author":"Ramirez","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0060","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1161\/01.CIR.0000126283.99195.37","article-title":"Water potentiates the pressor effect of ephedra alkaloids","volume":"109","author":"Jordan","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0061","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0002-9343(99)80246-0","article-title":"Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension","volume":"99","author":"Fouad-Tarazi","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0062","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/bmj.293.6543.353","article-title":"The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure","volume":"293","author":"Mathias","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0063","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10286-003-0052-3","article-title":"The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria","volume":"13","author":"Sakakibara","year":"2003","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0064","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1060028018786954","article-title":"Standing and supine blood pressure outcomes associated with droxidopa and midodrine in patients with neurogenic orthostatic hypotension: a Bayesian meta-analysis and mixed treatment comparison of randomized trials","volume":"52","author":"Chen","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0065","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00702-017-1791-y","article-title":"Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms","volume":"124","author":"Eschlbock","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0066","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jacc.2015.06.1084","article-title":"Orthostatic hypotension: epidemiology, prognosis, and treatment","volume":"66","author":"Ricci","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0067","series-title":"Full Prescribing Information","year":"2017"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0068","series-title":"Full Prescribing Information","year":"2017"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0069","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1524-6175.2001.00516.x","article-title":"Diagnosis and treatment of supine hypertension in autonomic failure patients with orthostatic hypotension","volume":"4","author":"Jordan","year":"2002","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0070","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-017-0867-5","article-title":"Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension","volume":"17","author":"Biaggioni","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0071","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mdc3.12726","article-title":"Six-month use of droxidopa for neurogenic orthostatic hypotension","volume":"6","author":"Fran\u00e7ois","year":"2019","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0072","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjcard.2016.11.066","article-title":"Cardiovascular safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension","volume":"119","author":"White","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0073","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cpdd.393","article-title":"Impact of the norepinephrine prodrug droxidopa on the QTc interval in healthy individuals","volume":"7","author":"White","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0074","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/mds.22226","article-title":"Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension","volume":"23","author":"Sharabi","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40268-018-0226-z","article-title":"Comparison of the pharmacokinetics of droxidopa after dosing in the fed versus fasted state and with 3-times-daily dosing in healthy elderly subjects","volume":"18","author":"Chen","year":"2018","journal-title":"Drugs R D"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0076","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00210-009-0474-0","article-title":"Cardiac adrenergic control and atrial fibrillation","volume":"381","author":"Workman","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0077","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(87)91317-1","article-title":"Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency","volume":"2","author":"Biaggioni","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0078","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","article-title":"Norepinephrine precursor therapy in neurogenic orthostatic hypotension","volume":"108","author":"Kaufmann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0079","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0024-3205(76)90210-1","article-title":"Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man","volume":"18","author":"Lake","year":"1976","journal-title":"Life Sci"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0080","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM197702102960601","article-title":"The sympathetic-nervous-system defect in primary orthostatic hypotension","volume":"296","author":"Ziegler","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0081","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11606-013-2520-3","article-title":"Midodrine for orthostatic hypotension: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Parsaik","year":"2013","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0082","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/0006-2952(87)90223-1","article-title":"Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-dopa","volume":"36","author":"Kato","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0083","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00228-005-0941-6","article-title":"Adverse drug reactions related to drugs used in orthostatic hypotension: a prospective and systematic pharmacovigilance study in France","volume":"61","author":"Pathak","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0084","unstructured":"Fludrocortisone acetate-Drug summary. Available at: http:\/\/www.pdr.net\/drug-summary\/Fludrocortisone-Acetate-fludrocortisone-acetate-1272. Accessed August 12, 2019."},{"key":"10.1016\/j.amjcard.2020.01.037_bib0085","series-title":"Full Prescribing Information","year":"2010"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0086","series-title":"Full Prescribing Information","year":"2007"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0087","series-title":"Full Prescribing Information","year":"2002"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0088","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10741-016-9541-z","article-title":"Heart failure and orthostatic hypotension","volume":"21","author":"Gorelik","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0089","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/HJH.0000000000002078","article-title":"Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension","volume":"37","author":"Jordan","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurheartj\/ehp329","article-title":"Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project)","volume":"31","author":"Fedorowski","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0091","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/HYPERTENSIONAHA.111.188151","article-title":"Orthostatic hypotension as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities study","volume":"59","author":"Jones","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0092","doi-asserted-by":"crossref","first-page":"e63169","DOI":"10.1371\/journal.pone.0063169","article-title":"Orthostatic hypotension and the risk of congestive heart failure: a meta-analysis of prospective cohort studies","volume":"8","author":"Xin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0093","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0094","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/jnnp.57.3.340","article-title":"Antiarrhythmic drugs and polyneuropathy","volume":"57","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0096","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.clinthera.2018.01.015","article-title":"Assessing the risk for peripheral neuropathy in patients treated with dronedarone compared with that in other antiarrhythmics","volume":"40","author":"Wu","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0097","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.2337\/diacare.27.12.2942","article-title":"Autonomic symptoms and diabetic neuropathy: a population-based study","volume":"27","author":"Low","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0098","series-title":"Data on File","year":"2017"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0099","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/europace\/eus425","article-title":"CLEAR Study Investigators. Effect of rate-adaptive pacing on performance and physiological parameters during activities of daily living in the elderly: results from the CLEAR (Cylos Responds with Physiologic Rate Changes during Daily Activities) study","volume":"15","author":"Abi-Samra","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.amjcard.2020.01.037_bib0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jnnp.65.3.285","article-title":"Treatment of postural hypotension","volume":"65","author":"Mathias","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920301028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920301028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:33:36Z","timestamp":1757572416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914920301028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0002914920301028"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.01.037","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.01.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}